The therapeutic potential of cell therapies is an established fact, but whether will they be able to overcome challenges posed by Solid Tumors remains a question. With innovative strategies, many types of cell therapies are being developed by Industry and academia with a focus on succeeding in Solid tumors. Engineered receptors (like CAR/ TCR), novel gene-editing techniques (CRISPR/ Transposons/ lentiviral, etc), scaling processes, etc are being developed to actualize the dream of transforming patients’ treatment through cell therapies.
Let’s explore the upcoming disruptive innovations that will bring about a paradigm shift in the development and success of cell therapies in solid tumors.
FutureBridge’s Oncology Analysts in this webinar cover:
Share your focus area or question to engage with our Analysts through the Business Objectives service.Submit My Business Objective
Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.